Kurt J. Hilzinger - Jun 30, 2022 Form 4 Insider Report for HUMANA INC (HUM)

Role
Director
Signature
Kurt J. Hilzinger
Stock symbol
HUM
Transactions as of
Jun 30, 2022
Transactions value $
$89,451
Form type
4
Date filed
7/5/2022, 09:38 AM
Previous filing
Apr 4, 2022
Next filing
Oct 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HUM Humana Common 19.4K Jun 30, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HUM Restricted Stock Units Award $89.5K +191 +1.67% $468.33 11.7K Jun 30, 2022 Humana Common 191 Direct F3
holding HUM Restricted Stock Units 22K Jun 30, 2022 Humana Common 22K Direct F1
holding HUM Restricted Stock Units 1.68K Jun 30, 2022 Humana Common 1.68K Direct F2
holding HUM Restricted Stock Units 412 Jun 30, 2022 Humana Common 412 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).
F2 Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).
F3 Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).
F4 Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/2022.